CORBF — Global Cord Blood Balance Sheet
0.000.00%
Last trade - 00:00HealthcareSpeculativeSmall Cap
- $140.61m
- -$772.78m
- CNY1.24bn
Annual balance sheet for Global Cord Blood, fiscal year end - March 31st, CNY millions except per share, conversion factor applied.
2018 March 31st | 2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 4,251 | 4,998 | 5,473 | 6,076 | 6,661 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 117 | 108 | 110 | 135 | 216 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 4,408 | 5,148 | 5,666 | 6,298 | 6,935 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 553 | 545 | 527 | 504 | 477 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 5,844 | 6,551 | 7,220 | 7,906 | 8,535 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 468 | 596 | 571 | 626 | 647 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2,731 | 3,134 | 3,338 | 3,524 | 3,655 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 3,113 | 3,417 | 3,882 | 4,382 | 4,879 |
| Total Liabilities & Shareholders' Equity | 5,844 | 6,551 | 7,220 | 7,906 | 8,535 |
| Total Common Shares Outstanding |